|
CHRNA5 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.020190E-03 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.299460E-03 |
| Normal-vs-Stage2 |
2.008800E-01 |
| Normal-vs-Stage3 |
3.577800E-03 |
| Normal-vs-Stage4 |
1.151980E-01 |
| Stage1-vs-Stage2 |
3.227200E-01 |
| Stage1-vs-Stage3 |
5.298800E-01 |
| Stage1-vs-Stage4 |
5.062200E-01 |
| Stage2-vs-Stage3 |
1.881610E-01 |
| Stage2-vs-Stage4 |
7.860800E-01 |
| Stage3-vs-Stage4 |
3.457400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.004000E-04 |
| Normal-vs-AfricanAmerican |
4.983600E-01 |
| Normal-vs-Asian |
2.428000E-01 |
| Caucasian-vs-AfricanAmerican |
1.747950E-01 |
| Caucasian-vs-Asian |
3.447800E-02 |
| AfricanAmerican-vs-Asian |
8.130200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.056190E-02 |
| Normal-vs-Female |
1.398750E-03 |
| Male-vs-Female |
9.753600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.120000E-03 |
| Normal-vs-Age(41-60Yrs) |
9.018200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.082800E-03 |
| Normal-vs-Age(81-100Yrs) |
5.444100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.886400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.994400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.765700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.095800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.122130E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.866800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.185400E-01 |
| Classical-VS-Follicular |
4.615200E-01 |
| Classical-VS-Other |
3.689600E-01 |
| Classical-VS-Normal |
1.562960E-03 |
| Tall-VS-Follicular |
1.682570E-01 |
| Tall-VS-Other |
6.474400E-01 |
| Tall-VS-Normal |
2.574400E-02 |
| Follicular-VS-Other |
1.664640E-01 |
| Follicular-VS-Normal |
8.639900E-02 |
| Other-VS-Normal |
1.504850E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.575200E-04 |
| Normal-vs-N1 |
1.704400E-02 |
| N0-vs-N1 |
8.403800E-01 |
|
|
